Ultrasound-guided peripheral intravenous (UGPIV) catheter insertions are commonly used to establish intravenous access in patients with difficult vascular access.

Communication and collaboration remain keys to successful healthcare

I Save That Podcast is supported by Parker Laboratories

Parker’s High-Level Disinfectant Foam Receives FDA de novo Clearance

UltraDrape® in Healthcare Purchasing News Article "Inserting Infection Prevention"

UltraDrape® in The Journal of the Association for Vascular Access Fall Issue "Survey of Ultrasound-Guided Peripheral Intravenous Access: A Report of Supply Usage and Variability Between Clinical Roles and Departments"

UltraDrape® in Infection Control Today Article "Better Barriers and Standardized Protocols: Improving UGPIV Safety"

Sterile Barrier Dressing Increases Efficiency and Safety of UGPIV Insertions, Pilot Study Finds

Parker Laboratories to Launch Groundbreaking Ultrasound Innovations at ENA 2023

Reducing Infection Risks for Ultrasound - Guided Percutaneous Performed by ED Nurses

State Agencies Grant Nationwide Access to Ultrasound Disinfectant from Parker Labs

FDA Grants De Novo Clearance to Tristel ULT™ as a High-Level Disinfectant for Ultrasound Applications

UltraDrape Makes Ultrasound-Guided PIV Insertions Safer, Easier and More Cost-Effective

Parker Labs Partners with Tristel to Deliver
Ultrasound Disinfectant for U.S. Market

Parker Laboratories Partners with Tristel

UltraDrape Reduces Cost of Ultrasound-Guided PIV Insertions, Increases Safety & Efficiency

Parker Labs Leads Investment in Solstice Pharmaceuticals' Innovative Ultrasound

Clinician Survey Reveals Significant Variation in Ultrasound-Guided PIV Insertion Practices

Protex® Disinfectants Can Be Used Against 2019 Novel Coronavirus

Survey Shows Patient Safety is Improved by Reducing Variability in Ultrasound-Guided PIV Insertions

Poll Finds Patient Safety is Threatened by Current Ultrasound-Guided PIV Insertion Techniques

UltraDrape® Barrier & Securement Dressing from Parker Laboratories Obtains CE Mark

Parker Laboratories Introduces World's First UGPIV Barrier and Securement Dressing

World's Ultrasound and Electromedical Industry Leader Celebrates 60th Anniversary

Medical Ultrasound Pioneer Expands New Jersey-Based Facilities

Parker Laboratories Unrelated to NJ Medical Device Manufacturer in Contaminated Ultrasound Gel Case

Honorary Doctor of Science Degree Conferred to Martin Buchalter, Founder, Parker Laboratories, Inc.

CDC Deems Protex® and Protex® ULTRA Suitable for Use in Suspected or Confirmed Cases of Ebola Virus Infection

Parker Laboratories Introduces Protex® ULTRA with Faster Kill Times and Expanded Pathogen Effectiveness

Parker Laboratories Introduces Newly Redesigned Thermasonic Gel Warmer

Parker Laboratories Expands Operating Space to Accommodate Growth

Parker Laboratories Products Remain Safe for Use...NOT in any way related to Newark, NJ Ultrasound Gel Seizure

Parker Laboratories is the Semi-Finialist of the 19th Annual New Jersey Family Business of the Year Award

Prudential Center Selects Protex^® as Exclusive Cleaner/Disinfectant for its Athletic Training Rooms